Saturday, June 11, 2011

Esophageal Hemorrhage Medications


There are currently no drugs listed for "Esophageal Hemorrhage".

Learn more about Esophageal Hemorrhage





Drug List:

Wednesday, June 8, 2011

AndroGel


See also: Generic Androderm


AndroGel is a brand name of testosterone, approved by the FDA in the following formulation(s):


ANDROGEL (testosterone - gel, metered; transdermal)



  • Manufacturer: ABBOTT LABS

    Approval date: September 26, 2003

    Strength(s): 1% (1.25GM/ACTIVATION) [RLD]


  • Manufacturer: ABBOTT LABS

    Approval date: April 29, 2011

    Strength(s): 1.62% (20.25MG/1.25GM ACTIVATION) [RLD]

ANDROGEL (testosterone - gel; transdermal)



  • Manufacturer: ABBOTT LABS

    Approval date: February 28, 2000

    Strength(s): 1% (2.5GM/PACKET)

Has a generic version of AndroGel been approved?


No. There is currently no therapeutically equivalent version of AndroGel available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of AndroGel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pharmaceutical composition and method for treating hypogonadism
    Patent 6,503,894
    Issued: January 7, 2003
    Inventor(s): Robert E.; Dudley & S. George; Kottayil & Olivier; Palatchi
    Assignee(s): Unimed Pharmaceuticals, Inc.
    Laboratories Besins Iscovesco
    A pharmaceutical composition useful for treating hypogonadism is disclosed. The composition comprises an androgenic or anabolic steroid, a C1-C4 alcohol, a penetration enhancer such as isopropyl myristate, and water. Also disclosed is a method for treating hypogonadism utilizing the composition.
    Patent expiration dates:

    • August 30, 2020
      ✓ 
      Patent use: TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE


    • August 30, 2020
      ✓ 
      Patent use: TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE


    • March 1, 2021
      ✓ 
      Pediatric exclusivity



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • April 29, 2014 - NEW PRODUCT

See also...

  • Androgel Consumer Information (Drugs.com)
  • AndroGel Gel Consumer Information (Wolters Kluwer)
  • AndroGel 2.5 g/packet Consumer Information (Cerner Multum)
  • AndroGel 5 g/packet Consumer Information (Cerner Multum)
  • AndroGel Packets Consumer Information (Cerner Multum)
  • AndroGel Pump 1.25 g/actuation Consumer Information (Cerner Multum)
  • Androgel Advanced Consumer Information (Micromedex)
  • Testosterone Consumer Information (Drugs.com)
  • Testosterone Consumer Information (Wolters Kluwer)
  • Testosterone Gel Consumer Information (Wolters Kluwer)
  • Testosterone Patch Consumer Information (Wolters Kluwer)
  • Testosterone Solution Consumer Information (Wolters Kluwer)
  • Testosterone buccal system Consumer Information (Cerner Multum)
  • Testosterone injection Consumer Information (Cerner Multum)
  • Testosterone topical Consumer Information (Cerner Multum)
  • Androplex Advanced Consumer Information (Micromedex)
  • Testosterone Buccal Advanced Consumer Information (Micromedex)
  • Testosterone Topical application Advanced Consumer Information (Micromedex)
  • Testosterone Transdermal Advanced Consumer Information (Micromedex)
  • Testosterone AHFS DI Monographs (ASHP)

Saturday, June 4, 2011

Claribiotic




Claribiotic may be available in the countries listed below.


Ingredient matches for Claribiotic



Clarithromycin

Clarithromycin is reported as an ingredient of Claribiotic in the following countries:


  • Argentina

  • Dominican Republic

International Drug Name Search

Wednesday, June 1, 2011

Trichinosis Medications


Definition of Trichinosis: Trichinosis is a roundworm (Trichinella spiralis) infection, usually contracted by eating raw or undercooked meat.

Drugs associated with Trichinosis

The following drugs and medications are in some way related to, or used in the treatment of Trichinosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Trichinosis





Drug List:

Friday, May 27, 2011

Gonadotrophine




Gonadotrophine may be available in the countries listed below.


Ingredient matches for Gonadotrophine



Gonadotrophin, Serum

Gonadotrophin, Serum is reported as an ingredient of Gonadotrophine in the following countries:


  • Tunisia

International Drug Name Search

Thursday, May 26, 2011

Penicilina G Benzatinica Genfar




Penicilina G Benzatinica Genfar may be available in the countries listed below.


Ingredient matches for Penicilina G Benzatinica Genfar



Benzylpenicillin

Benzylpenicillin is reported as an ingredient of Penicilina G Benzatinica Genfar in the following countries:


  • Ecuador

Benzylpenicillin benzathine (a derivative of Benzylpenicillin) is reported as an ingredient of Penicilina G Benzatinica Genfar in the following countries:


  • Colombia

International Drug Name Search

Tim-Alcon




Tim-Alcon may be available in the countries listed below.


Ingredient matches for Tim-Alcon



Timolol

Timolol is reported as an ingredient of Tim-Alcon in the following countries:


  • Lithuania

International Drug Name Search